SHA/688336 (SHA/688336)

Shanghai Stock Exchange: SHA/688336 · CNY

CN¥32.5

+0.43 (+1.3%)· Recorded snapshot

Market cap	29.1B
Revenue (ttm)	4.5B
Net income (ttm)	3.1B
EPS (ttm)	CN¥3.44
Shares out	896.3M
P/E (trailing)	9.4x
P/E (forward)	45.2x
Dividend	CN¥0.33 (1.02%)
Volume	4,092,424
Beta	0.33

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.5B
Net income (ttm): 3.1B
EPS (ttm): CN¥3.44
P/E (trailing): 9.4x
P/E (forward): 45.2x
Market cap: 29.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E45.2

P25 n/aP50 n/aP75 n/a

Trailing P/E9.4

P25 n/aP50 n/aP75 n/a

ROE42.6

P25 n/aP50 n/aP75 n/a

ROIC56

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/688336 indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-23
Employees	1,023
Employees change	11
Employees growth	1.09%
Enterprise value	CNY 27.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2002
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CNE1000062X2
Last earnings date	2026-10-23
Last refreshed	2026-10-28
Last stock split date	2026-06-18
Last stock split type	Forward
Market cap	CNY 29.1B
Next earnings date	2026-10-30
Price	CNY 32.49
Price currency	CNY
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	sha/688336
Website	https://3s-guojian.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	28.78x
Average P/E ratio (5Y)	114.6x
Earnings yield	10.59%
EV/Earnings	8.77x
EV/EBIT	7.93x
EV/EBITDA	7.67x
EV/Sales	6.05x
FCF / EV yield	-0.27%
FCF yield	-0.25%
Forward P/E	45.15x
Graham number	27.37768
Graham upside	-15.89%
Industry forward P/E	36.91x
Lynch fair value	CNY 86.04
Lynch upside	164.32%
P/(OCF - SBC) ratio	161.89x
P/B ratio	3.33x
P/E ratio	9.44x
P/OCF ratio	140.89x
P/S ratio	6.42x
Price / tangible book value	3.46x
Price/EBITDA ratio	8.47x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	73.14%
EBITDA margin	75.82%
Effective tax rate	12.53%
Gross margin	92.49%
Operating margin	73.14%
Pretax margin	78.8%
Profit margin	68.99%
Profit per employee	CNY 3.1M
Profitable quarters	17
Profitable years	5
Revenue per employee	CNY 4.4M
ROA	22.93%
ROA (5Y)	5.78%
ROCE	37.55%
ROE	42.58%
ROE (5Y)	12.33%
ROIC	55.97%
ROIC (5Y)	19.23%
SBC / revenue	0.59%
Tax / revenue	9.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	259.49%
EPS growth (Q)	4.44%
EPS growth (QoQ)	14.44%
EPS growth 3Y	142.1%
EPS growth years	5
Gross profit growth	298.65%
Gross profit growth (Q)	6.73%
Gross profit growth 3Y	73.56%
Gross profit growth 5Y	50.84%
Net income growth	254.77%
Net income growth (Q)	3.65%
Net income growth (QoQ)	11.87%
Net income growth 3Y	144.2%
Net income growth quarters	9
Net income growth years	5
OCF growth	-93%
OCF growth (Q)	-98.49%
OCF growth (QoQ)	-55.28%
OCF growth 3Y	-19.15%
Operating income growth	855.93%
Operating income growth (Q)	-10.24%
Operating income growth 3Y	168.18%
Revenue growth	226.65%
Revenue growth (Q)	11.14%
Revenue growth (QoQ)	21.25%
Revenue growth 3Y	63.25%
Revenue growth 5Y	45.05%
Revenue growth quarters	7
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -276M
Depreciation and amortization	CNY 120.1M
EBIT	CNY 3.3B
EBITDA	CNY 3.4B
EPS	CNY 3.44
FCF per share	CNY -0.08
Financing cash flow	CNY -282.9M
Free cash flow	CNY -72M
Free cash flow minus SBC	CNY -98.5M
Gross profit	CNY 4.1B
Income taxes	CNY 441.9M
Investing cash flow	CNY 24.5M
Net cash flow	CNY -53.8M
Net income	CNY 3.1B
Operating cash flow minus SBC	CNY 177.5M
Operating income	CNY 3.3B
Revenue	CNY 4.5B
Stock-based compensation	CNY 26.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	63.45
Book value per share	CNY 9.68
Debt / equity	0
Goodwill	CNY 639,600
Interest coverage	11,899.12
Long-term assets	CNY 2.8B
Long-term liabilities	CNY 85.9M
Net cash (debt)	CNY 1.6B
Net cash / market cap	5.56%
Net cash growth	-7.29%
Net debt / EBITDA	-0.47
Net debt / equity	-0.19
Piotroski F-Score	6
Property, plant and equipment	CNY 1.6B
Shareholders' equity	CNY 8.6B
Tangible book value	CNY 8.3B
Tangible book value per share	CNY 9.27
Total assets	CNY 9B
Total cash	CNY 1.6B
Total debt	CNY 0
Total liabilities	CNY 400.6M
WACC	6.07%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.5
Current assets	CNY 6.3B
Current liabilities	CNY 314.7M
Current ratio	19.96
Inventory turnover	1.27
Net working capital	CNY 4.4B
Quick ratio	6.52
Working capital	CNY 6B
Working capital turnover	1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.31%
Dividend growth	457.3%
Dividend growth years	1
Dividend payment date	2026-06-18
Dividend payment years	3
Dividend payout frequency	Semi-Annual
Dividend per share	CNY 0.33
Dividend yield	1.03%
Ex-dividend date	2026-06-18
Last dividend	CNY 0.45
Payout ratio	9.67%
Shareholder yield	2.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 45.55
1D price change	1.34%
1M price change	-17.14%
1M total return	-17.14%
1W price change	-5.5%
1W total return	-5.5%
1Y price change	-15.07%
1Y return CAGR	-14.35%
1Y total return	-14.34%
20-day SMA	CNY 36.29
200-day SMA	CNY 44.43
3M price change	-25.87%
3M total return	-25.87%
3Y price change	112.69%
3Y return CAGR	29.21%
3Y total return	115.74%
50-day SMA	CNY 40.45
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 66.62
52-week high date	2026-04-03
52-week low	CNY 31.47
52-week low date	2026-10-23
5Y price change	162.02%
5Y return CAGR	21.6%
5Y total return	165.78%
6M price change	-38.22%
6M total return	-37.72%
All-time high	CNY 66.62
All-time high date	2026-04-03
All-time low	CNY 8.24
All-time low date	2022-10-12
Average true range (ATR)	CNY 1.82
Average volume	5.4M
Beta (1Y)	0.63
Beta (2Y)	0.4
Beta (5Y)	0.33
Change from 52-week high	-51.23%
Change from 52-week low	3.24%
Change from all-time high	-51.23%
Change from all-time low	294.25%
Change from open	-0.31%
Day's gap	1.65%
Dollar volume	CNY 133M
High price	CNY 33.15
Low price	CNY 32.00
Monthly RSI	47.21
Open price	CNY 32.59
Position in 52-week range	42.61%
Previous close	CNY 32.06
Price vs 150-day SMA	-28.67%
Price vs 20-day SMA	-10.47%
Price vs 200-day SMA	-26.87%
Price vs 50-day SMA	-19.67%
Relative volume	0.72
RSI	32.31
Sharpe ratio	0.19
Sharpe ratio (3Y)	0.74
Sharpe ratio (5Y)	0.5
Sortino ratio	0.41
Sortino ratio (3Y)	1.4
Sortino ratio (5Y)	0.98
Volume	4.1M
Weekly RSI	39.27
YTD price change	-20.92%
YTD total return	-20.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	138.5M
Shares change (QoQ)	-2.25%
Shares change (YoY)	-1.31%
Shares held by insiders	3.15%
Shares held by institutions	7.3%
Shares outstanding	896.3M

Deeper analysis on SHA/688336

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/688336 report

Is a complete SHA/688336 research report available?

No complete published report is available for sha/688336 (SHA/688336) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/688336 (SHA/688336)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/688336

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/688336 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/688336

Frequently asked questions